A ground-breaking British technology that prevents Middle Eastern cancer patients from losing their hair during chemotherapy will be showcased at Arab Health 2020.Read More.
HCA UK is joining the HSMA delegation at Arab Health 2020 – as part of the 17 world-leading clinics and hospital groups showcasing London’s medical excellence at the largest healthcare trade exhibition in the Middle East.Read More.
John Bell & Croyden – holders of the Royal Warrant from Her Majesty the Queen –will be attending Arab Health […]Read More.
Findings related to FLASH Radiotherapy could pave a new path for the future for cancer therapyRead More.
The red, tube-shaped flowers of the firecracker bush (Bouvardia ternifolia), native to Mexico and the American Southwest, attract hummingbirds. The […]Read More.
Complex heart surgery which hopes to give the best possible chance of survival to children diagnosed with heart problems, including congenital heart disease, will be demonstrated on the ABHI UK Pavilion at Arab Health 2020.Read More.
The Middle East Medical Portal (MEMP) have a reach of 49,000 subscribers, c-12,000+ monthly website views, c-22,000+ LinkedIn connections, and […]Read More.
The London Clinic, the UK’s leading independent private hospital and charity, located in London’s Harley Street Medical Area, is showcasing […]Read More.
In a new qualitative study, a team of scientists at Dartmouth and Dartmouth-Hitchcock’s Norris Cotton Cancer Center and the Breast Cancer Surveillance Consortium led by Karen Schifferdecker, PhD, MPH, and Anna Tosteson, ScD, sought to explore women’s knowledge and perceptions of breast density and experiences of breast cancer screening across three states with and without notification laws.Read More.
Immune checkpoint inhibitors are important medications that boost the immune system’s response against certain cancers; however, they tend to be ineffective against glioblastoma, the most deadly primary brain tumour in adults. New research in mice led by investigators at Massachusetts General Hospital (MGH) and the University of Florida reveals a promising strategy that makes glioblastoma susceptible to these medications.Read More.